Your browser doesn't support javascript.
loading
Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial.
Chiang, Chi Leung; Lam, Tai Chung; Li, James Chun Bong; Chan, Kenneth Sik Kwan; El Helali, Aya; Lee, Yolanda Yim Ping; Law, Laalaa Hiu Ting; Zheng, Danyang; Lo, Anthony Wing Ip; Kam, Ngar Woon; Li, Wing Sum; Cheung, Alice Ka Wai; Chow, James Chung Hang; Chan, Sunny Po Chung; Lai, Jessica Wing Yu; Lee, Sarah Wai Man; Kong, Feng-Ming Spring; Ng, Wai Tong; Kwong, Dora Lai Wan; Lee, Anne Wing Mui.
Affiliation
  • Chiang CL; LKS Faculty of Medicine, Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong and University of Hong Kong-Shenzhen Hospital, China.
  • Lam TC; LKS Faculty of Medicine, Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong and University of Hong Kong-Shenzhen Hospital, China.
  • Li JCB; LKS Faculty of Medicine, Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, The University of Hong Kong, China.
  • Chan KSK; LKS Faculty of Medicine, Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong, China.
  • El Helali A; LKS Faculty of Medicine, Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong, China.
  • Lee YYP; Department of Diagnostic Radiology, Gleneagles Hospital (Hong Kong), China.
  • Law LHT; LKS Faculty of Medicine, Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, The University of Hong Kong, China.
  • Zheng D; LKS Faculty of Medicine, Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong, China.
  • Lo AWI; Department of Pathology, Queen Mary Hospital, Hong Kong, China.
  • Kam NW; LKS Faculty of Medicine, Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong, China.
  • Li WS; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.
  • Cheung AKW; Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, China.
  • Chow JCH; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.
  • Chan SPC; Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, China.
  • Lai JWY; Department of Clinical Oncology, Princess Margaret Hospital, Hong Kong, China.
  • Lee SWM; Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
  • Kong FS; LKS Faculty of Medicine, Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong and University of Hong Kong-Shenzhen Hospital, China.
  • Ng WT; LKS Faculty of Medicine, Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong and University of Hong Kong-Shenzhen Hospital, China.
  • Kwong DLW; LKS Faculty of Medicine, Department of Clinical Oncology, School of Clinical Medicine, The University of Hong Kong and University of Hong Kong-Shenzhen Hospital, China.
  • Lee AWM; LKS Faculty of Medicine, Department of Clinical Oncology, University of Hong Kong-Shenzhen Hospital and School of Clinical Medicine, The University of Hong Kong, China.
Lancet Reg Health West Pac ; 40: 100898, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37701718

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Reg Health West Pac Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Lancet Reg Health West Pac Year: 2023 Document type: Article Affiliation country: Country of publication: